| 6/22/2009 | DD | AtheroGenics out of bankruptcy; trustee to make plan distributions
|
| 6/16/2009 | DD | AtheroGenics' net loss improves to $364,317 in May on zero revenues
|
| 6/9/2009 | DD | AtheroGenics liquidation plan approved
|
| 6/2/2009 | DD | AtheroGenics confirmation hearing ends with plan taken under advisement
|
| 5/20/2009 | DD | AtheroGenics reports operating loss shrinks to $1.44 million in April
|
| 4/20/2009 | DD | AtheroGenics posts $1.5 million operating loss, no revenues in March
|
| 4/15/2009 | DD | AtheroGenics' plan-vote solicitation exclusivity extended to June 12
|
| 4/15/2009 | DD | AtheroGenics disclosure statement OK'd; confirmation hearing June 2
|
| 3/27/2009 | DD | AtheroGenics $2 million non-cash asset sale approved
|
| 3/27/2009 | DD | AtheroGenics requests two-month extension to exclusive plan-solicitation period
|
| 3/20/2009 | DD | AtheroGenics posts $1.11 million February operating loss
|
| 3/17/2009 | DD | AtheroGenics non-cash asset sale procedures approved
|
| 3/12/2009 | DD | AtheroGenics sets bid procedures for sale of non-cash assets
|
| 2/19/2009 | DD | AtheroGenics reports $1.06 million January operating loss
|
| 2/12/2009 | DD | AtheroGenics files plan of reorganization
|
| 1/22/2009 | DD | AtheroGenics initial purchase offer deadline passes; debt to exceed proceeds, cash on hand
|
| 1/20/2009 | DD | AtheroGenics records $1.27 million December operating loss
|
| 12/18/2008 | DD | AtheroGenics posts $1.17 million November operating loss
|
| 12/3/2008 | DD | AtheroGenics posts $1.32 million October operating loss
|
| 11/17/2008 | DD | AtheroGenics records $7.47 million third-quarter operating loss
|
| 10/17/2008 | DD | AtheroGenics unsecured creditors committee appointed
|
| 10/7/2008 | CVDD | AtheroGenics agrees to convert case to Chapter 11, plans to sell assets
|
| 9/23/2008 | DD | AtheroGenics reduces workforce by 40%
|
| 9/16/2008 | CVDDSS | AtheroGenics noteholders file involuntary Chapter 7 bankruptcy petition
|
| 9/2/2008 | CVDDSS | AtheroGenics to skip note payments, evaluate restructuring alternatives; noteholder proposal rejected
|
| 8/20/2008 | CVDDSS | AtheroGenics considering exchange of 4.5% convertible notes
|
| 8/11/2008 | CVDDSS | AtheroGenics considers bankruptcy as one convertible repayment option
|
| 5/9/2008 | CVDDSS | AtheroGenics 4.5% convertibles repayment to leave company short of cash for 2009
|
